Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ALNYLAM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 652,366 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $259.4M as of 2025-Q4. The position was decreased (-7.9% shares). ALNY represents 0.1% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$259.4M
Current Shares
652,366
Total Value Change
+$56.4M
Total Shares Change
-183,047
Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 652,366 |
-7.9% |
| $259.4M |
| 0.1% |
| $397.25 |
0 |
| 2025-Q3 | Decreased | 708,564 | -26.1% | $323.1M | 0.1% | $447.49 | 0 |
| 2025-Q2 | Increased | 958,336 | +30.2% | $312.5M | 0.1% | $322.83 | 39 |
| 2025-Q1 | Increased | 736,111 | +3.6% | $198.8M | 0.1% | $268.46 | 32 |
| 2024-Q4 | Increased | 710,598 | +0.6% | $167.2M | 0.0% | $236.01 | 30 |
| 2024-Q3 | Decreased | 706,231 | -15.5% | $194.2M | 0.0% | $274.91 | 0 |
| 2024-Q2 | Increased | 835,413 | +10.1% | $203M | 0.1% | $243.00 | 34 |